fludarabine and panobinostat

fludarabine has been researched along with panobinostat in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Dai, Y; Dent, P; Grant, S; Hock, S; Rosato, R	1

Other Studies

1 other study(ies) available for fludarabine and panobinostat

Article	Year
LBH-589 (panobinostat) potentiates fludarabine anti-leukemic activity through a JNK- and XIAP-dependent mechanism. Leukemia research, 2012, Volume: 36, Issue:4 Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Blotting, Western; Cell Line, Tumor; Down-Regulation; Drug Synergism; Electrophoretic Mobility Shift Assay; Enzyme Activation; Enzyme-Linked Immunosorbent Assay; Humans; Hydroxamic Acids; Indoles; Leukemia; MAP Kinase Kinase 4; Mice; Mice, Nude; NF-kappa B; Panobinostat; Vidarabine; X-Linked Inhibitor of Apoptosis Protein	2012

Article

Year

LBH-589 (panobinostat) potentiates fludarabine anti-leukemic activity through a JNK- and XIAP-dependent mechanism.

Leukemia research, 2012, Volume: 36, Issue:4

Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Blotting, Western; Cell Line, Tumor; Down-Regulation; Drug Synergism; Electrophoretic Mobility Shift Assay; Enzyme Activation; Enzyme-Linked Immunosorbent Assay; Humans; Hydroxamic Acids; Indoles; Leukemia; MAP Kinase Kinase 4; Mice; Mice, Nude; NF-kappa B; Panobinostat; Vidarabine; X-Linked Inhibitor of Apoptosis Protein

2012